Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Apr;108(4):1038–1042. doi: 10.1111/j.1476-5381.1993.tb13502.x

Inhibition of nerve stimulation-induced vasodilatation in corpora cavernosa of the pithed rat by blockade of nitric oxide synthase.

J P Finberg 1, S Levy 1, Y Vardi 1
PMCID: PMC1908165  PMID: 7683562

Abstract

1. The effect of inhibition of nitric oxide synthase by NG-nitro-L-arginine methyl ester (L-NAME) on nerve stimulation-induced vasodilation in corpora cavernosa was studied in the pithed rat. Corporal vasodilation was estimated by the increase in ratio (corpora cavernosal pressure/systemic blood pressure; CP/BP) following electrical stimulation of the sacral part of the spinal cord. 2. L-NAME (2, 5, 10 and 25 mg kg-1) caused an increase in BP and a dose-dependent inhibition of the rise in the CP/BP ratio following stimulation. 3. The inhibitory effect of L-NAME (25 mg kg-1) on the corporal response to spinal cord stimulation, as well as the pressor response, was partially prevented by prior administration of L- but not D-arginine (400 mg kg-1, i.v.). 4. L-NAME (20 mg kg-1, i.v.) did not inhibit the rise in corporal pressure resulting from direct intracavernosal administration of papaverine (400 micrograms over 2 min). However, this response was inhibited by 5-hydroxytryptamine (20 micrograms kg-1, i.v.). 5. The results are indicative of a role of nitric oxide (NO) in the corporal vasodilator response to erectile stimulation.

Full text

PDF
1038

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki H., Takagane H., Matsuzaka J., Banya Y., Fujioka T., Nakaya S., Kubo T., Ohhori T. Quantitative analysis of outflow pathway of corpora cavernosa by pressure flow technique. J Urol. 1989 Mar;141(3):645–650. doi: 10.1016/s0022-5347(17)40924-4. [DOI] [PubMed] [Google Scholar]
  2. Brindley G. S. Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis. Br J Pharmacol. 1986 Mar;87(3):495–500. doi: 10.1111/j.1476-5381.1986.tb10191.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burnett A. L., Lowenstein C. J., Bredt D. S., Chang T. S., Snyder S. H. Nitric oxide: a physiologic mediator of penile erection. Science. 1992 Jul 17;257(5068):401–403. doi: 10.1126/science.1378650. [DOI] [PubMed] [Google Scholar]
  4. Dail W. G., Hamill R. W. Parasympathetic nerves in penile erectile tissue of the rat contain choline acetyltransferase. Brain Res. 1989 May 15;487(1):165–170. doi: 10.1016/0006-8993(89)90953-0. [DOI] [PubMed] [Google Scholar]
  5. Finberg J. P., Vardi Y. Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat. Br J Pharmacol. 1990 Nov;101(3):698–702. doi: 10.1111/j.1476-5381.1990.tb14143.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol. 1990 Nov;101(3):625–631. doi: 10.1111/j.1476-5381.1990.tb14131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holmquist F., Stief C. G., Jonas U., Andersson K. E. Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol Scand. 1991 Nov;143(3):299–304. doi: 10.1111/j.1748-1716.1991.tb09236.x. [DOI] [PubMed] [Google Scholar]
  8. Ignarro L. J., Bush P. A., Buga G. M., Wood K. S., Fukuto J. M., Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun. 1990 Jul 31;170(2):843–850. doi: 10.1016/0006-291x(90)92168-y. [DOI] [PubMed] [Google Scholar]
  9. Kim N., Azadzoi K. M., Goldstein I., Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest. 1991 Jul;88(1):112–118. doi: 10.1172/JCI115266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Liu X. R., Gillespie J. S., Gibson I. F., Martin W. Effects of NG-substituted analogues of L-arginine on NANC relaxation of the rat anococcygeus and bovine retractor penis muscles and the bovine penile artery. Br J Pharmacol. 1991 Sep;104(1):53–58. doi: 10.1111/j.1476-5381.1991.tb12384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lue T. F., Tanagho E. A. Physiology of erection and pharmacological management of impotence. J Urol. 1987 May;137(5):829–836. doi: 10.1016/s0022-5347(17)44267-4. [DOI] [PubMed] [Google Scholar]
  12. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  13. Moore P. K., al-Swayeh O. A., Chong N. W., Evans R. A., Gibson A. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol. 1990 Feb;99(2):408–412. doi: 10.1111/j.1476-5381.1990.tb14717.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mülsch A., Busse R. NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):143–147. doi: 10.1007/BF00195071. [DOI] [PubMed] [Google Scholar]
  15. Pickard R. S., Powell P. H., Zar M. A. The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve-evoked relaxation of human cavernosal smooth muscle. Br J Pharmacol. 1991 Nov;104(3):755–759. doi: 10.1111/j.1476-5381.1991.tb12500.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Roy J. B., Petrone R. L., Said S. I. A clinical trial of intracavernous vasoactive intestinal peptide to induce penile erection. J Urol. 1990 Feb;143(2):302–304. doi: 10.1016/s0022-5347(17)39939-1. [DOI] [PubMed] [Google Scholar]
  17. Stief C., Benard F., Bosch R., Aboseif S., Nunes L., Lue T. F., Tanagho E. A. Acetylcholine as a possible neurotransmitter in penile erection. J Urol. 1989 Jun;141(6):1444–1448. doi: 10.1016/s0022-5347(17)41342-5. [DOI] [PubMed] [Google Scholar]
  18. Willis E., Ottesen B., Wagner G., Sundler F., Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Acta Physiol Scand. 1981 Dec;113(4):545–547. doi: 10.1111/j.1748-1716.1981.tb06936.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES